Mycoprotein, a fungal food sold mainly as Quorn, reliably lowers total and "bad" cholesterol within weeks when it replaces meat, increases fullness, supports muscle-building as well as animal protein, and improves some gut-health markers; blood-sugar effects are less consistent. Main drawbacks are digestive discomfort and a rare risk of serious allergic reactions, especially in mold-allergic people. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | < 100 mg/dL | Primary marker expected to improve with meat substitution |
| Total cholesterol | < 180 mg/dL | The marker most consistently lowered in mycoprotein trials |
| HDL cholesterol | > 50–60 mg/dL | Confirms substitution does not adversely shift the lipid profile |
| Fasting glucose | 70–90 mg/dL | Tracks any metabolic benefit and overall glucose control |
| HbA1c | < 5.4% | Captures longer-term glycemic trend better than a single glucose reading |
| Uric acid | 3.5–6.0 mg/dL | Screens for any nucleotide-related rise, relevant in gout-prone individuals |
| hs-CRP | < 1.0 mg/L | Optional marker of overall dietary-pattern improvement |
Cadence: Baseline, then ~8–12 weeks after a consistent dietary change, then every 6–12 months.